Tag: CDC

  • Keeping Ill Workers Home Reduces Transmission of Both Infectious and Foodborne Diseases

    Key Points: In today’s Recommendations for Industry, we discuss keeping ill workers home to reduce both infectious and foodborne diseases. Read more below. To handle the rise in COVID-19 cases, the U.S. government is again sending free COVID-19 tests to U.S. households. In this 3rd round of free at-home tests, you will receive 8 tests…

  • COVID Variants Continue Impacting NE U.S.

    Key Points: In today’s Recommendations for Industry, we discuss the latest COVID transmissibility data from both TAG’s matrix and CDC’s mapping. Read more below. Today, North Korea imposed a nationwide lockdown as it’s acknowledging its first confirmed COVID-19 outbreak (AP News).  COVID-19 cases continue to rise in Africa and the Americas. In fact, “16 major…

  • Variants Continue to Evolve. What Does it Mean for Your Business?

    Key Points: In today’s Recommendations for Industry, we discuss the continuing evolution of COVID variants and what this means for your business. Read more below. The CDC has put out more information on long-COVID and Post-COVID conditions. The CDC currently discusses Post-COVID conditions by: “Some people who have been infected with the virus that causes…

  • COVID Vaccine: How Effective Are They Against Variants?

    Key Points: In today’s Recommendations for Industry, we discuss how well the various COVID vaccines work against the variants. Read more below. The CDC estimates that, until now, about “60% of adults and 75% of children” have antibodies indicating that they’ve been infected with COVID-19 (CNN). Moderna has asked the FDA to authorize its vaccine…

  • Number of Factors Keeping U.S. COVID Rates Low

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and the “gentle swell” of COVID in the U.S. Read more below. CDC: 58% of Americans have had COVID-19. New COVID-19 seroprevalence data from CDC show that the Omicron surge infected a huge swath of Americans, with overall seroprevalence rising from 33.5% in December of…

  • COVID Vaccines: The Current and Projected Status

    Key Points: In today’s Recommendations for Industry, we discuss the current and projected status of COVID-19 vaccines. Read more below. COVID-19 Was Third Leading Cause of Death in U.S. last year. In 2021, COVID-19 was the third leading cause of death in the U.S., as the Delta and Omicron waves drove the pandemic’s death toll…

  • Travel Mask Mandate “Outlawed” – What this Means to your Business

    Key Points: In today’s Recommendations for Industry, we discuss the dropping of the travel mask mandate. Read more below. Declaring the COVID-19 travel mask mandate to be unlawful, U.S. District Judge Kathryn Kimball Mizelle in Tampa said the mandate exceeded the authority granted to the CDC under federal public health law; that Congress had never…

  • COVID Case Nudges No Cause for Behavior Change

    Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news.  Read more below. The CDC has extended mask mandates on planes through May 3 (NYT). The FDA has “granted an extension for the shelf life of the authorized” Pfizer vaccine; vials can be stored, frozen, at ultra-low…

  • COVID Levels – Follow the Curve

    Key Points: In today’s Recommendations for Industry, we discuss following the curve. Read more below. Extending TSA mask mandate ‘absolutely’ still on the table. On Monday, a top White House COVID-19 adviser said that extending the federal mask mandate for all transportation networks, which is set to expire April 18, is “absolutely” under consideration. Centers…

  • New England Cases Rise – What’s It Really Mean?

    Key Points: In today’s Recommendations for Industry, we discuss what the COVID case increase in the New England States means for the U.S. Read more below. New England states are reporting a sharp increase in daily COVID-19 cases driven by the Omicron subvariant, BA.2. This rise in numbers (up to and over 40% in cases)…